4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001171843-26-001267
Chief Executive Officer bought 50,571 shares at an average $1.96 ($99,176)
- Chief Executive Officer acquired 10,016 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nijhawan Pardeep · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-26 | Purchase : show line 1 in the form | +20,571 | $1.58 | $32,480 | 615,797 | D |
| 2026-03-02 | Grant or award : show line 2 in the form | +10,016 | 625,813 | D | ||
| 2026-02-27 | Purchase : show line 3 in the form | +30,000 | $2.22 | $66,696 | 371,702 | I |
| Open-market purchases · 50,571 sh · avg $1.96 · $99,176 | ||||||
Loading xslF345X05/ownership.xml…